BSE filing, NSE: KOLTEPATIL. Summary written from the filing by ALFA Finder's alert engine.
Kolte-Patil Developers Ltd: key numbers
- Share price
- ₹456.65
- Market cap
- ₹4,050 Cr
- Revenue (annual)
- ₹735.0 Cr
- Net profit (annual)
- ₹-38.67 Cr
- P/E (TTM)
- 32.5×Sector 33.7×
- Promoter holding
- 73.81%+0.00% QoQ
- FII holding
- 11.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kolte-Patil Developers Ltd
All →Kolte-Patil Developers Other Announcement
Kolte-Patil Developers filed CARE Ratings' monitoring report on preferential issue proceeds for the quarter ended 30 September 2026. The report records no deviation from the offer objects.
Kolte-Patil Developers Board Meeting Date
Kolte-Patil Developers intimated a board meeting on November 3, 2026 to consider unaudited standalone and consolidated results for Q2 and half-year ended September 30, 2026. The notice is advance intimation with agenda proposed only.
Kolte-Patil Developers Price Movement Clarification
Kolte-Patil responded to an NSE surveillance query on a volume spurt, stating no material event or undisclosed information. The company is unaware of any development behind the trading increase.
Kolte-Patil Developers Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory compliance disclosure.
Kolte-Patil Developers Business Update
Kolte-Patil Developers reported record quarterly sales of Rs. 1,019 crore for Q2 FY27 and signed six new redevelopment projects in Mumbai worth Rs. 6,000 crore GDV.
- Value
- ₹6,000 Cr
Kolte-Patil Developers Credit Rating
CARE Ratings has reaffirmed the 'CARE AA-; Stable' rating for Kolte-Patil Developers Limited's Non-Convertible Debentures. The rating covers an instrument amount of Rs. 250 Crore.
- Value
- ₹250.0 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date